Susquehanna International Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
52,410
-4,195
| -7% | -$213K | ﹤0.01% | 1959 |
|
|
2025
Q1 | $2.55M | Buy |
56,605
+30,861
| +120% | +$1.39M | ﹤0.01% | 1973 |
|
|
2024
Q4 | $1.06M | Buy |
25,744
+10,151
| +65% | +$420K | ﹤0.01% | 2898 |
|
|
2024
Q3 | $608K | Sell |
15,593
-19,370
| -55% | -$755K | ﹤0.01% | 3376 |
|
|
2024
Q2 | $1.2M | Buy |
34,963
+10,608
| +44% | +$363K | ﹤0.01% | 2332 |
|
|
2024
Q1 | $612K | Buy |
24,355
+16
| +0.1% | +$402 | ﹤0.01% | 3271 |
|
|
2023
Q4 | $718K | Sell |
24,339
-8,514
| -26% | -$251K | ﹤0.01% | 3336 |
|
|
2023
Q3 | $1.04M | Buy |
32,853
+15,987
| +95% | +$505K | ﹤0.01% | 2525 |
|
|
2023
Q2 | $436K | Sell |
16,866
-51,881
| -75% | -$1.34M | ﹤0.01% | 3798 |
|
|
2023
Q1 | $1.65M | Buy |
68,747
+47,900
| +230% | +$1.15M | ﹤0.01% | 2201 |
|
|
2022
Q4 | $407K | Sell |
20,847
-5,994
| -22% | -$117K | ﹤0.01% | 3487 |
|
|
2022
Q3 | $564K | Sell |
26,841
-1,102
| -4% | -$23.2K | ﹤0.01% | 3370 |
|
|
2022
Q2 | $544K | Buy |
27,943
+3,336
| +14% | +$64.9K | ﹤0.01% | 3242 |
|
|
2022
Q1 | $542K | Buy |
24,607
+660
| +3% | +$14.5K | ﹤0.01% | 3610 |
|
|
2021
Q4 | $382K | Sell |
23,947
-63,451
| -73% | -$1.01M | ﹤0.01% | 4174 |
|
|
2021
Q3 | $1.74M | Buy |
87,398
+76,987
| +739% | +$1.53M | ﹤0.01% | 2105 |
|
|
2021
Q2 | $180K | Sell |
10,411
-2,942
| -22% | -$50.9K | ﹤0.01% | 4892 |
|
|
2021
Q1 | $265K | Buy |
+13,353
| New | +$265K | ﹤0.01% | 4487 |
|